Skip to main content
Year archive

Cantargia — 2018 filings

All 11 regulatory filings released by Cantargia (CANTA) in 2018, sourced directly from the official regulator.

11 Filings
2018 Period
2018 filings (11)
Filing Released Lang
Cantargia presenterar nya positiva prekliniska data för antikroppen CAN04 på en större antikroppskonferens
Regulatory Filings
2018-12-10 Swedish
Cantargia presents new positive preclinical data on antibody CAN04 at major antibody conference
Regulatory Filings
2018-12-10 English
Cantargia: Fas I säkerhetsutvärderingsdelen av CANFOUR studien med antikroppen CAN04 är genomförd och fas IIa-delen initieras
Legal Proceedings Report
2018-12-07 Swedish
Cantargia: Phase I safety evaluation part of CANFOUR trial of antibody CAN04 completed and phase IIa part being initiated
Legal Proceedings Report
2018-12-07 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-15 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-15 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-08 English
Cantargia AB: Valberedning utsedd inför årsstämman 2019
Board/Management Information
2018-10-30 Swedish
Cantargia AB: Nomination Committee appointed ahead of 2019 Annual General Meeting
Board/Management Information
2018-10-30 English
Cantargia presenterade positiva kliniska fas I-data av läkemedelskandidaten CAN04 vid ESMO
Regulatory Filings
2018-10-20 Swedish
Cantargia presented positive phase I clinical data with lead candidate CAN04 at ESMO
Regulatory Filings
2018-10-20 English